Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
108.41
+1.14 (1.06%)
Nov 4, 2024, 4:00 PM EST - Market closed
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $1.82B in the quarter ending September 30, 2024, with 4.03% growth. This brings the company's revenue in the last twelve months to $7.60B, up 4.35% year-over-year. In the year 2023, Zimmer Biomet Holdings had annual revenue of $7.39B with 6.55% growth.
Revenue (ttm)
$7.60B
Revenue Growth
+4.35%
P/S Ratio
2.93
Revenue / Employee
$421,972
Employees
18,000
Market Cap
21.58B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
Dec 31, 2019 | 7.98B | 49.30M | 0.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical | 16.29B |
Labcorp Holdings | 12.71B |
STERIS | 5.23B |
Moderna | 5.05B |
Illumina | 4.43B |
Hologic | 3.99B |
The Cooper Companies | 3.80B |
BeiGene | 3.10B |
ZBH News
- 5 days ago - Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts - Benzinga
- 5 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Implant maker Zimmer Biomet lowers full-year profit forecast - Reuters
- 5 days ago - Zimmer Biomet Announces Third Quarter 2024 Financial Results - PRNewsWire
- 7 days ago - Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting - PRNewsWire
- 26 days ago - Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results - PRNewsWire
- 4 weeks ago - Large Joint Devices Market Size, Share, and Global Trends Analysis 2024-2030: Zimmer Biomet Leads Global Hip Reconstruction Market with Taperloc and Arcos Systems - GlobeNewsWire
- 4 weeks ago - Zimmer Biomet: The Undervalued Titan Of Joint Replacements - Seeking Alpha